SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-119100
Filing Date
2023-11-16
Accepted
2023-11-16 16:08:39
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2330778-1_s3.htm S-3 347101
2 EXHIBIT 5.1 tm2330778d2_ex5-1.htm EX-5.1 10130
3 EXHIBIT 23.1 tm2330778d2_ex23-1.htm EX-23.1 2083
4 EXHIBIT 23.2 tm2330778d2_ex23-2.htm EX-23.2 1873
5 EX-FILING FEES tm2330778d2_ex-filingfees.htm EX-FILING FEES 14432
6 GRAPHIC lg_immunome-4c.jpg GRAPHIC 16978
7 GRAPHIC tm2330778d2_ex5-1img01.jpg GRAPHIC 5303
  Complete submission text file 0001104659-23-119100.txt   407578
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275598 | Film No.: 231414673
SIC: 2834 Pharmaceutical Preparations